The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|36|5976-5989

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.36, 2012-12, pp. : 5976-5989

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5929-5941

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Biomarker Research for Pancreatic Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 17, 2012-06 ,pp. : 2439-2451

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolomics Analysis for Biomarker Discovery: Advances and Challenges

By  

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 257-271

Bentham Science Publishers

Access to resources Recommend Favorite

Latest advances in computational genotoxicity prediction

By Naven Russell T   Greene Nigel   Williams Richard V  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1579-1587

Informa Healthcare

Access to resources Recommend Favorite

Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes

By Beck Zoltan   Karasavvas Nicos   Matyas Gary   Alving Carl  

Journal of Drug Targeting, Vol. 16, Iss. 7-8, 2008-08 ,pp. : 535-542

Informa Healthcare

Access to resources Recommend Favorite